Yidong Yu

Dr. Yidong Yu

Würzburg University Hospital
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2020 in mBio
Verified
Journal Article
Open access
PDF file
JAJorge Amich
Jorge Amich
ZMZeinab Mokhtari
Zeinab Mokhtari
MSMarlene Strobel
Marlene Strobel
EVElena Vialetto
Elena Vialetto
DSDalia Sheta
Dalia Sheta
ABAndreas Beilhack
Andreas Beilhack
The use of animal models of infection is essential to advance our understanding of the complex host-pathogen interactions that take place during Aspergillus fumigatus lung infections. As in the case of humans, mice need to suffer an immune imbalance in order to become susceptible to invasive pulmonary aspergillosis (IPA), the most serious infection caused by A. fumigatus . There are several immunosuppressive regimens that are routinely used to investigate fungal growth and/or immune responses in murine models of invasive pulmonary aspergillosis. However, the precise consequences of the use of each immunosuppressive model for the local immune populations and for fungal growth are not completely understood. Here, to pin down the scenarios involving commonly used IPA models, we employed light sheet fluorescence microscopy (LSFM) to analyze whole lungs at cellular resolution. Our results will be valuable to optimize and refine animal models to maximize their use in future research.

21 September 2018 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
Yidong YuYidong Yu
Yidong Yu
ABAdriana Blachowicz
Adriana Blachowicz
CWCornelia Will
Cornelia Will
ESEdyta Szewczyk
Edyta Szewczyk
SGSteven Glenn
Steven Glenn
Sven KrappmannSven Krappmann
Sven Krappmann

1 November 2017 in Fungal Genetics and Biology
Verified
Journal Article
Closed access
Yidong YuYidong Yu
Yidong Yu
JAJorge Amich
Jorge Amich
CWCornelia Will
Cornelia Will
CECarly E. Eagle
Carly E. Eagle
PDPaul Dyer
Paul Dyer
Sven KrappmannSven Krappmann
Sven Krappmann

30 June 2020 in Biomacromolecules
Verified
Journal Article
Closed access
SHSonja Horvat
Sonja Horvat
Yidong YuYidong Yu
Yidong Yu
SBSzalbolcs Böjte
Szalbolcs Böjte
ITIngrid Tessmer
Ingrid Tessmer
DLDouglas W. Lowman
Douglas W. Lowman
JGJürgen Groll
Jürgen Groll

6 August 2020 in Expert Opinion on Investigational Drugs
Verified
Journal Article
Open access
Yidong YuYidong Yu
Yidong Yu
KAKrystyna Albrecht
Krystyna Albrecht
JGJürgen Groll
Jürgen Groll
ABAndreas Beilhack
Andreas Beilhack
The incidence of life-threatening invasive fungal infections (IFIs) has increased significantly in recent years. Current therapeutic options for IFIs are limited. Only four major classes of antifun...

13 February 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Yidong YuYidong Yu
Yidong Yu
AWAnn-Katrin Wolf
Ann-Katrin Wolf
STSina Thusek
Sina Thusek
HTHeinekamp Thorsten
Heinekamp Thorsten
MBMike Bromley
Mike Bromley
ABAndreas Beilhack
Andreas Beilhack
Invasive fungal infections (IFIs) are difficult to diagnose and to treat and, despite several available antifungal drugs, cause high mortality rates. In the past decades, the incidence of IFIs has continuously increased. More recently, SARS-CoV-2-associated lethal IFIs have been reported worldwide in critically ill patients. Combating IFIs requires a more profound understanding of fungal pathogenicity to facilitate the development of novel antifungal strategies. Animal models are indispensable for studying fungal infections and to develop new antifungals. However, using mammalian animal models faces various hurdles including ethical issues and high costs, which makes large-scale infection experiments extremely challenging. To overcome these limitations, we optimized an invertebrate model and introduced a simple calcofluor white (CW) staining protocol to macroscopically and microscopically monitor disease progression in silkworms (Bombyx mori) infected with the human pathogenic filamentous fungi Aspergillus fumigatus and Lichtheimia corymbifera. This advanced silkworm A. fumigatus infection model could validate knockout mutants with either attenuated, strongly attenuated or unchanged virulence. Finally, CW staining allowed us to efficiently visualize antifungal treatment outcomes in infected silkworms. Conclusively, we here present a powerful animal model combined with a straightforward staining protocol to expedite large-scale in vivo research of fungal pathogenicity and to investigate novel antifungal candidates.